Document is current
Any future updates will be listed below
-
Authors
Al Zegair, Fatima
Betz-Stablein, Brigid
Janda, Monika
Soyer, H. Peter
Chandra, Shekhar S.
-
Funding
Funding for this research was provided by:
The University of Queensland
- License Information
-
More Information
Article History
Received: 11 December 2024
Accepted: 21 August 2025
First Online: 17 September 2025
Declarations
:
: HPS is a shareholder of MoleMap NZ Limited and e-derm consult GmbH and undertakes regular teledermatological reporting for both companies. HPS is a Medical Consultant for Canfield Scientific Inc, MoleMap Australia Pty Ltd, Blaze Bioscience Inc, and a Medical Advisor for First Derm.
: This study was approved by the Metro South Human Research Ethics Committee (approval #HREC/09/QPAH/ 162, 26 August 2009) and The University of Queensland (approval #2009001590, 14 October 2009) and conducted in accordance with the Declaration of Helsinki. Participants provided written consent after receiving a Participant Information and Consent Form.
